• 1
    Novick AC,Streem S,Montie JE, et al. Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol. 1989; 141: 835839.
  • 2
    Novick AC. The role of renal-sparing surgery for renal cell carcinoma. Semin Urol. 1992; 10: 1215.
  • 3
    Fergany AF,Hafez KS,Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol. 2000; 163: 442445.
  • 4
    Hafez KS,Fergany AF,Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999; 162: 19301933.
  • 5
    Lerner SE,Hawkins CA,Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996; 155: 18681873.
  • 6
    Lee CT,Katz J,Shi W,Thaler HT,Reuter VE,Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000; 163: 730736.
  • 7
    McKiernan J,Simmons R,Katz J,Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002; 59: 816820.
  • 8
    Lau WK,Blute ML,Weaver AL,Torres VE,Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clinic Proc. 2000; 75: 12361242.
  • 9
    Huang WC,Levey AS,Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006; 7: 735740.
  • 10
    Lesage K,Joniau S,Fransis K,Van Poppel H. Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol. 2007; 51: 614620.
  • 11
    Kutikov A,Fossett LK,Ramchandani P. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. 2006; 68: 737740.
  • 12
    Hollingsworth JM,Miller DC,Daignault S,Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006; 98: 13311334.
  • 13
    Miller DC,Hollingsworth JM,Hafez KS,Daignault S,Hollenbeck BK. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol. 2006; 175: 853857.
  • 14
    Hollenbeck BK,Taub DA,Miller DC,Dunn RL,Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006; 67: 254259.
  • 15
    Van Poppel H,Da Pozzo L,Albrecht W, et al. A prospective randomized EORTC Intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2007; 51: 16061615.
  • 16
    Go AS,Chertow GM,Fan D,McCullogc CE,Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 12961305.
  • 17
    Schoolwerth AC,Engelgau MM,Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis. 2006; 3: 16.
  • 18
    Hafez KS,Novick AC,Butler BP. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol. 1998; 159: 11561160.
  • 19
    Hankey BF,Ries LA,Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8: 11171121.
  • 20
    Warren JL,Klabunde CN,Schrag D,Bach PB,Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40( 8 suppl): 318.
  • 21
    Bach PB,Guadagnoli E,Schrag D,Schussler N,Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002; 40( 8 suppl): IV-1925.
  • 22
    Klabunde CN,Potosky AL,Legler JM,Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 12581267.
  • 23
    Klabunde CN,Harlan LC,Warren JL. Data sources for measuring comorbidity: a comparison of hospital records and Medicare claims for cancer patients. Med Care. 2006; 44: 921928.
  • 24
    Winkelmayer WC,Schneeweiss S,Mogun H,Patrick AR,Avorn J,Solomon DH. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005; 46: 225232.
  • 25
    Winkelmayer WC,Glynn RJ,Levin R,Owen WF,Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001; 38: 11781184.
  • 26
    Foley RN,Murray AM,Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005; 16: 489495.
  • 27
    Xue JL,Daniels F,Star RA, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006; 17: 11351142.
  • 28
    Joffe MM,Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999; 150: 327333.
  • 29
    D'Agostino RBJr,D'Agostino RBSr. Estimating treatment effects using observational data. JAMA. 2007; 297: 314316.
  • 30
    Stukel TA,Fisher ES,Wennberg DE,Alter DA,Gottlieb DJ,Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007; 297: 278285.
  • 31
    Licht MR,Novick AC. Nephron sparing surgery for renal cell carcinoma. J Urol. 1993; 149: 17.
  • 32
    Gorodetskaya I,Zenios S,McCulloch CE, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005; 68: 28012808.
  • 33
    Fukuhara S,Yamazaki S,Marumo F, et al. Health-related quality of life of predialysis patients with chronic renal failure. Nephron. 2007; 105: c1c8.
  • 34
    Altintepe L,Levendoglu F,Okudan N, et al. Physical disability, psychological status, and health-related quality of life in older hemodialysis patients and age-matched controls. Hemodial Int. 2006; 10: 260266.
  • 35
    Okechukwu CN,Lopes AA,Stack AG,Feng S,Wolfe RA,Port FK. Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivors. Am J Kidney Dis. 2002; 39: 533538.
  • 36
    Wolfe RA,Ashby VB,Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341: 17251730.
  • 37
    Shih YC,Guo A,Just PM,Mujais S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int. 2005; 68: 319329.
  • 38
    Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors–United States, 1999–2004. MMWR Morbid Mortal Weekly Rep. 2007; 56: 161165.
  • 39
    Bijol V,Mendez GP,Hurwitz S,Rennke HG,Nose V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol. 2006; 30: 575584.
  • 40
    Patard JJ,Shvarts O,Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004; 171: 21812185.
  • 41
    Katz SJ,Hawley ST. From policy to patients and back: surgical treatment decision making for patients with breast cancer. Health Affairs. 2007; 26: 761769.